Learn how Alendronate or Fosamax that is osteoporosis medication affects the risk of an irregular heart beat in this medical report.
Read the full transcript »
Dr. Susan Sharma: This is Insidermedicine in 60. From Washington; Taking Alendronate or Fosamax for osteoporosis may raise the risk of irregular heart beat. In a study where over 700 women with atrial fibrillation were compared to nearly 1,000 controls, those who took Fosamax had a 50% higher risk of developing atrial fibrillation. Up to 3% of all new cases of atrial fibrillation may be attributed to Alendronate use. From London; Molecular treatments may be close for common retinal conditions like macular degeneration and retinitis pigmentosa. Researchers sought to evaluate the safety and effectiveness of molecular therapy in three patients with an uncommon retinal condition called Leber's Congenital Amaurosis. Healthy copies of faulty genes were delivered into the deepest layers of the retina of the patients by using a non-pathogenic virus. The treatment was safe in all patients and one experienced improved function. Finally from California; Researchers looked at the prevalence of diabetes and women who had a child in 1999 and compared it to women in 2005. Over a six year period, the prevalence of diabetes more than doubled and its risk increased five fold among teenagers who were having babies. Eating well, exercising and maintaining a healthy weight are critical to having a healthy pregnancy and avoiding diabetes. For Insidermedicine in 60, I'm Doctor Susan Sharma.